当前位置: X-MOL 学术JAMA Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
JAMA Oncology
JAMA Oncology ( IF 28.4 ) Pub Date : 2020-03-01 , DOI: 10.1001/jamaoncol.2019.4209


JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.

Mission Statement: JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.

Mary L. (Nora) Disis, MD, Seattle, Washington



中文翻译:

JAMA肿瘤学

JAMA肿瘤学致力于发表有影响力的原创性研究,观点和评论,以促进肿瘤学的发展并改善癌症患者的临床护理。

任务说明:《JAMA肿瘤学》是面向全球肿瘤学领域的科学家,临床医生和受训人员的权威杂志。我们原创,创新,及时的科学和教育内容为读者提供了对癌症发病机理和最新治疗进展的更深入了解。JAMA肿瘤学旨在将重要的临床研究结果,重大的科学突破,可行的发现以及最新的治疗途径传达给肿瘤学界。我们的目标是成功传播新知识最终将为癌症患者和幸存者带来临床益处。

玛丽·L·····(Nora)Disis,MD,华盛顿西雅图

更新日期:2020-03-12
down
wechat
bug